Valuation: Omnicell, Inc.

Market Cap 1.7B 1.47B 1.38B 1.26B 2.37B 162B 2.41B 16.15B 6.34B 81.2B 6.39B 6.25B 270B P/E 2026 *
37.9x
P/E 2027 * 36.8x
Enterprise Value 1.7B 1.47B 1.38B 1.26B 2.37B 162B 2.41B 16.15B 6.34B 81.2B 6.39B 6.25B 270B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.32x
Free-Float
76.33%
Yield 2026 *
-
Yield 2027 * -
1 day+1.36%
1 week-0.90%
Current month+5.48%
1 month-16.94%
3 months-14.86%
6 months-4.33%
Current year-17.64%
1 week 35.88
Extreme 35.88
37.6
1 month 34.86
Extreme 34.86
48.06
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Sell

Chief Executive Officer

-10,000 0.0220%
1/7/26 Free

Chairperson

12,309 0.0271%
1/4/26 Free

Chief Administrative Officer

25,132 0.0553%
Change 5-day change 1-year change 3-year change Capi.($)
+1.36%-0.90%+21.02%-41.88% 1.7B
+1.83%+13.79%-16.81%+21.82% 38.12B
+3.24%+5.50%-40.17%+164.13% 13.04B
+0.33%+0.74%-22.89%+68.09% 5.5B
+1.84%+9.68%+2.09% - 2.53B
+2.58%+2.65% - - 1.89B
-2.17%-2.10%-34.02% - 1.06B
-0.86%+5.28%+35.00%+122.82% 907M
+1.65%+2.50%-32.29%-46.68% 847M
+1.28%+14.49%+670.73%+887.50% 815M
Average +1.08%+81.90%+64.74%+167.97% 6.64B
Weighted average by Cap. +1.86%+187.71%-11.39%+66.79%

Financials

2026 *2027 *
Net sales 1.24B 1.07B 1B 915M 1.72B 118B 1.75B 11.74B 4.61B 59.02B 4.64B 4.54B 197B 1.29B 1.12B 1.04B 953M 1.8B 123B 1.82B 12.22B 4.8B 61.47B 4.84B 4.73B 205B
Net income 45.27M 39.19M 36.63M 33.48M 63.09M 4.32B 64.08M 430M 169M 2.16B 170M 166M 7.19B 47.37M 41.01M 38.33M 35.03M 66.01M 4.52B 67.04M 449M 176M 2.26B 178M 174M 7.53B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
10/08/26 US$37.31 +1.36% 529,257
07/08/26 US$36.81 +1.80% 754,895
06/08/26 US$36.16 -2.72% 503,213
05/08/26 US$37.17 +0.05% 699,654
04/08/26 US$37.15 -1.33% 1,200,575
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
37.31USD
Average target price
57.86USD
Spread / Average Target
+55.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock